Reply to 'Comment on Cancer incidence in the United Kingdom: Projections to the year 2030'

British Journal of Cancer

Volumn 108, Issue 5, 2013, Pages 1215-1217

  Ahmad, A S ^a   Parkin, D M ^a   Sasieni, P D ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BLADDER CANCER; BRAIN CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; COLORECTAL CANCER; ESOPHAGUS CANCER; HUMAN; KIDNEY CANCER; LETTER; LEUKEMIA; LIVER CANCER; LUNG CANCER; MAMMOGRAPHY; MELANOMA; MOUTH CANCER; MYELOMA; NERVOUS SYSTEM TUMOR; NONHODGKIN LYMPHOMA; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; STOMACH CANCER; TESTIS CANCER; UNITED KINGDOM; UTERINE CERVIX CANCER; UTERUS CANCER;

FEMALE; HUMANS; MALE; NEOPLASMS;

EID: 84875464128     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.72     Document Type: Letter

References (4)

1. Midthune DN, Fay MP, Clegg LX, Feuer EJ (2005) Modeling reporting delaysand reporting corrections in cancer registry data. J Am Stat Assoc100 (469) : 61-70.
2. Mistry M, Parkin DM, Ahmad AS, Sasieni P (2011) Cancer incidence in theUnited Kingdom: projections to the year 2030. Br J Cancer 105: 1795-1803.
3. National Cancer Institute (2012) Cancer Query Systems Delay-Adjusted SEERIncidence Rates. http://surveillance.cancer.gov/delay/canques.html (accessed 21 January 2013) .
4. Oliver SE, Roman E, Crouch S, Bolton E, Ferguson B (2013) Comment on'Cancer incidence in the United Kingdom: projections to the year 2030'.Br J Cancer 108: 1213-1214.